CD33 and acute myeloid leukemia: The burden of AML in shME2-THP-1 and shME2-MV4-11 mice was determined five weeks after xenotransplantation by monitoring the proportional change of CD33 + and CD45 + cells in the peripheral blood and bone marrow (Figures S5 and S6, respectively).